Dose Ranging Study in Healthy Methadone Maintenance Subjects

Bausch Health

Status and phase: Completed; Phase 1

Conditions: Adult

Treatments: Drug: MOA-728

Study type: Interventional

Funder types: Industry

Identifiers

NCT00387491

3200A3-102

Details and patient eligibility

About

To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

1. Men or nonlactating and nonpregnant women, aged 18 to 65 years
2. Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind